Objective: Few large-scale studies have focused on the effect of gynecologic cancer compared with other biopsychosocial factors on willingness to seek treatment among women with sexual dysfunction. The aim of study was to identify predictors of the intention to treat female sexual dysfunction (FSD) among sociodemographic factors, physiologic factors, psychologic factors, gynecologic cancer, and health belief model (HBM).
Materials And Methods: This study was a cross-sectional, hospital-based survey conducted from October 2013 to September 2019.
Background: In gynecologic cancer survivors, female sexual dysfunction (FSD) remains under-investigated. We attempted to estimate the prevalence of FSD associated with distress in gynecologic cancer survivors using diagnostic and statistical manual of mental disorders fifth edition (DSM-5) diagnostic criteria and to identify women at risk for FSD.
Methods: We conducted a cross-sectional analysis of premenopausal women aged 20-50 with various gynecologic cancers at least one year after treatment between January 2017 and December 2019.
Taiwan J Obstet Gynecol
December 2018
Objective: Hypoactive Sexual Desire Disorder (HSDD) was the most common subtype of female sexual dysfunction; however, little was known about why Chinese women with HSDD were willing to seek medical help. This study aimed to identify predictive factors of seeking treatment for HSDD.
Materials And Methods: 260 outpatient premenopausal women who met the DSM-IV-TR criteria for HSDD for at least 6 months were recruited.
J Minim Invasive Gynecol
November 2005
Study Objective: To evaluate the efficacy of intraoperative infusion of bupivacaine solution for the relief of pain after operative gynecologic laparoscopy.
Design: Prospective, double-blind, randomized, controlled trial (Canadian Task Force classification I4).
Setting: Tertiary teaching hospital.
Objective: To determine the accuracy of differential diagnosis by team consultation of abortion in progression, low-lying implantation/cervicoisthmic pregnancy, and cervical pregnancy (CP) in patients referred for suspicion of abnormal implantation on the lower segment and cervix of the uterus and to determine the efficacy of endoscopic surgery with uterine artery blockade followed by cervical evacuation in the treatment of confirmed CP.
Design: Prospective observational study under multiple-clinic and multiple-hospital cooperation.
Setting: Tertiary clinical and academic medical center.
We prenatally diagnosed MELAS syndrome in a fetus whose mother and older brother had the MELAS-specific A3243G mutation. The mutant mtDNA level of the amniotic fluid cells was not significantly different from that of the postnatal peripheral blood and hair follicle samples. The obstetrical course was uncomplicated except for transient exacerbation of the mother's diabetes, which required insulin control.
View Article and Find Full Text PDF